The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model
- PMID: 24269312
- DOI: 10.1016/j.arr.2013.10.002
The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model
Abstract
Alzheimer's disease (AD) is a widespread and devastating progressive neurodegenerative disease. Disease-modifying treatments remain beyond reach, and the etiology of the disease is uncertain. Animal model are essential for identifying disease mechanisms and developing effective therapeutic strategies. Research on AD is currently being carried out in rodent models. The most common transgenic mouse model mimics familial AD, which accounts for a small percentage of cases. The senescence-accelerated mouse prone 8 (SAMP8) strain is a spontaneous animal model of accelerated aging. Many studies indicate that SAMP8 mice harbor the behavioral and histopathological signatures of AD, namely AD-like cognitive and behavioral alterations, neuropathological phenotypes (neuron and dendrite spine loss, spongiosis, gliosis and cholinergic deficits in the forebrain), β-amyloid deposits resembling senile plaques, and aberrant hyperphosphorylation of Tau-like neurofibrillary tangles. SAMP8 mice are useful in the development of novel therapies, and many pharmacological agents and approaches are effective in SAMP8 mice. SAMP8 mice are considered a robust model for exploring the etiopathogenesis of sporadic AD and a plausible experimental model for developing preventative and therapeutic treatments for late-onset/age-related AD, which accounts for the vast majority of cases.
Keywords: Alzheimer's disease; Cognition; Learning and memory; Senescence-accelerated mouse prone 8 strain; Tau hyperphosphorylation; β-Amyloid deposit.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.J Neurol Sci. 2013 Dec 15;335(1-2):145-54. doi: 10.1016/j.jns.2013.09.018. Epub 2013 Sep 21. J Neurol Sci. 2013. PMID: 24095271
-
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.J Alzheimers Dis. 2015;46(4):877-88. doi: 10.3233/JAD-143090. J Alzheimers Dis. 2015. PMID: 25869785 Free PMC article.
-
Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.Neurosci Lett. 2013 Dec 17;557 Pt B:84-9. doi: 10.1016/j.neulet.2013.10.051. Epub 2013 Oct 28. Neurosci Lett. 2013. PMID: 24176881
-
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8).J Alzheimers Dis. 2008 Dec;15(4):615-24. doi: 10.3233/jad-2008-15408. J Alzheimers Dis. 2008. PMID: 19096160 Review.
-
SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease.J Alzheimers Dis. 2020;75(2):385-395. doi: 10.3233/JAD-200063. J Alzheimers Dis. 2020. PMID: 32310176 Review.
Cited by
-
Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise.Front Aging Neurosci. 2014 Mar 20;6:51. doi: 10.3389/fnagi.2014.00051. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24688469 Free PMC article.
-
Effects of Bushen-Yizhi formula on age-related inflammation and oxidative stress in senescence-accelerated mice.Mol Med Rep. 2018 May;17(5):6947-6960. doi: 10.3892/mmr.2018.8736. Epub 2018 Mar 14. Mol Med Rep. 2018. PMID: 29568888 Free PMC article.
-
Reassessment of Pioglitazone for Alzheimer's Disease.Front Neurosci. 2021 Jun 16;15:666958. doi: 10.3389/fnins.2021.666958. eCollection 2021. Front Neurosci. 2021. PMID: 34220427 Free PMC article. Review.
-
Microalgae Aurantiochytrium Sp. Increases Neurogenesis and Improves Spatial Learning and Memory in Senescence-Accelerated Mouse-Prone 8 Mice.Front Cell Dev Biol. 2021 Feb 9;8:600575. doi: 10.3389/fcell.2020.600575. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33634096 Free PMC article.
-
Bioanalytical Method Development Using Liquid Chromatography with Amperometric Detection for the Pharmacokinetic Evaluation of Forsythiaside in Rats.Molecules. 2016 Oct 16;21(10):1384. doi: 10.3390/molecules21101384. Molecules. 2016. PMID: 27754467 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical